Publicado en línea de su impresión el 25 de Mayo de 2017. DOI: 10.1200/J0P.2017.021949
Silvia de Sanjosé, Sarah Temin, Suzanne Garland, Linda O'Neal Eckert, y Silvina Arrossi.
¿Cuál es el método óptimo para la prevención primaria del cáncer cervicouterino?
Población en general.
Autoridades de salud pública, profesionales del control de cáncer, encargados de la formulación de políticas, obstetras/ginecólogos, pediatras y otros proveedores de atención primaria, público en general.
La vacuna es la estrategia óptima para la prevención primaria de la infección por algunos tipos de virus del papiloma humano que pueden causar cáncer cervicouterino en la población objetivo. No hay otra estrategia preventiva para este cáncer que pueda sustituir la vacuna.
The Clinical Practice Guidelines and other guidance published herein are provided by the American Society of Clinical Oncology, Inc. (ASCO) to assist providers in clinical decision making. The information herein should not be relied upon as being complete or accurate, nor should it be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. With the rapid development of scientific knowledge, new evidence may emerge between the time information is developed and when it is published or read. The information is not continually updated and may not reflect the most recent evidence. The information addresses only the topics specifically identified therein and is not applicable to other interventions, diseases, or stages of diseases. This information does not mandate any particular course of medical care. Further, the information is not intended to substitute for the independent professional judgment of the treating provider, as the information does not account for individual variation among patients. Recommendations specify the level of confidence that the recommendation reflects the net effect of a given course of action. The use of words like “must,” “must not,” “should,” and “should not” indicates that a course of action is recommended or not recommended for either most or many patients, but there is latitude for the treating physician to select other courses of action in individual cases. In all cases, the selected course of action should be considered by the treating provider in the context of treating the individual patient. Use of the information is voluntary. ASCO does not endorse third party drugs, devices, services, or therapies used to diagnose, treat, monitor, manage, or alleviate health conditions. Any use of a brand or trade name is for identification purposes only. ASCO provides this information on an “as is” basis and makes no warranty, express or implied, regarding the information. ASCO specifically disclaims any warranties of merchantability or fitness for a particular use or purpose. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this information, or for any errors or omissions.